http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106692167-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83fd27146af30c39a1c81c15533e5bc1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
filingDate 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106692167-A
titleOfInvention Chinese and western medicine composition for treating epilepsy
abstract The invention discloses a Chinese and western medicine composition for treating epilepsy. The Chinese and western medicine composition is composed of the following raw materials in parts by weight: 1-5 parts of saffloside, 6-14 parts of ursolic acid, 11-19 parts of cuscohygrine and 15-23 parts of aminophylline. The preparation method comprises the following steps: mixing and grinding ursolic acid and cuscohygrine, adding an aminophylline solution, stirring and treating at the temperature of 52 DEG C for 30-33 minutes, and performing ultrasonic treatment at the temperature of 45 DEG C for 20 minutes at the ultrasonic power of 700W; then adding saffloside, and performing microwave treatment for 3 minutes at the microwave power of 800W; and stirring at the temperature of 63 DEG C until the solution is dry, and granulating, thereby obtaining the product. The Chinese and western medicine composition disclosed by the invention is used for treating epilepsy, achieves the aim of treating both symptoms and root causes and is fast in efficacy and excellent in long-term effects, and the epilepsy is difficult to reoccur. The Chinese and western medicine composition disclosed by the invention is small in dosage, high in cure rate, low in reoccurrence rate and low in price, does not have any toxic or side effect or anaphylactic reaction and is easily accepted by patients.
priorityDate 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1201543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13073352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448855826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554

Total number of triples: 29.